Related Experiment Video
Updated: Jan 8, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Dynamic Prediction of Analysis Timing in Clinical Trials Using Joint Models of Longitudinal and Time-to-Event Data.
Ryunosuke Machida1,2, Kentaro Sakamaki3,4, Tomohiro Ohigashi5
1Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.
Predicting clinical trial analysis timing is crucial for resource management. A new method using longitudinal data, like prostate-specific antigen (PSA) levels, improves prediction accuracy compared to methods using only baseline data.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Longitudinal Data Analysis
Background:
- Event-driven clinical trials rely on timely analysis for resource management.
- Current prediction methods often overlook valuable longitudinal covariate data.
- Accurate analysis timing is critical for optimizing trial costs and operations.
Purpose of the Study:
- To develop and evaluate a novel method for predicting clinical trial analysis timing.
- To incorporate longitudinally measured covariates into dynamic prediction models.
- To compare the proposed method against existing approaches using varying covariate data.
Main Methods:
- Developed a dynamic prediction method using joint models for time-to-event outcomes and longitudinal covariates.
- Compared prediction accuracy against methods using no covariates and only baseline covariates.
- Utilized simulated data and assessed performance based on prediction accuracy.
Main Results:
- The proposed method incorporating longitudinal covariates significantly improved prediction accuracy for analysis timing.
- Methods relying solely on baseline or no covariates showed lower prediction accuracy.
- Numerical experiments confirmed the enhanced performance of the joint modeling approach.
Conclusions:
- Joint models integrating longitudinal covariate data offer superior accuracy in predicting clinical trial analysis timing.
- This approach is particularly valuable for trials with time-to-event endpoints and available longitudinal measurements.
- The developed method provides a robust tool for optimizing clinical trial planning and resource allocation.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Comparing the Survival Analysis of Two or More Groups
Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

